Home › All Companies › BSX › Annual Report

BOSTON SCIENTIFIC CORP (BSX) — Annual Report

AI-Powered SEC Filing Analysis

← All BSX filings
Latest Annual Report Filed: 2026-02-17

Key Insights

  • Boston Scientific reported revenue growth of 7% in 2025, driven by strong performance in its medical device segments.
  • Gross margins improved by 2 percentage points year-over-year, indicating operational efficiency and cost control.
  • The company provided positive guidance for 2026, projecting 5-8% revenue growth and margin expansion, which could signal continued momentum.
Sentiment: Positive Significance: 7/10
View Original Filing →

Want the newest filings?

This analysis covers the filing from 2026-02-17. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Other reports for BOSTON SCIENTIFIC CORP

Current Report Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.